Acuta Capital Partners, LLC Vista Gen Therapeutics, Inc. Transaction History

Acuta Capital Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.88 - $1.73 $329,852 - $648,459	-374,832 Reduced 3.19%	11,361,451 $10 Million
Q4 2021 Feb 14, 2022	BUY	$1.67 - $2.76 $13,777 - $22,770	8,250 Added 0.07%	11,736,283 $22.9 Million
Q2 2021 Aug 16, 2021	SELL	$1.96 - $3.15 $1.11 Million - $1.79 Million	-567,734 Reduced 4.62%	11,728,033 $36.9 Million
Q1 2021 May 17, 2021	BUY	$1.89 - $2.96 $9.06 Million - $14.2 Million	4,795,767 Added 63.94%	12,295,767 $26.2 Million
Q4 2020 Feb 16, 2021	BUY	$0.65 - $1.94 $4.88 Million - $14.6 Million	7,500,000 New	7,500,000 $14.6 Million

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $610M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Acuta Capital Partners, LLC with notifications on news.